SEMPRA - SRE 5 3/4 07/01/2079 (SREA) Fundamental Analysis & Valuation

NYSE:SREA • US8168516040

Current stock price

21.7 USD
+0.01 (+0.05%)
Last:

This SREA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. SREA Profitability Analysis

1.1 Basic Checks

  • SREA had positive earnings in the past year.
  • In the past year SREA had a positive cash flow from operations.
  • In the past 5 years SREA has always been profitable.
  • SREA had a positive operating cash flow in each of the past 5 years.
SREA Yearly Net Income VS EBIT VS OCF VS FCFSREA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B 4B -4B 6B -6B

1.2 Ratios

  • The Return On Assets of SREA (1.62%) is worse than 80.77% of its industry peers.
  • SREA's Return On Equity of 5.68% is on the low side compared to the rest of the industry. SREA is outperformed by 84.62% of its industry peers.
  • With a Return On Invested Capital value of 2.14%, SREA is not doing good in the industry: 92.31% of the companies in the same industry are doing better.
  • Measured over the past 3 years, the Average Return On Invested Capital for SREA is in line with the industry average of 3.75%.
Industry RankSector Rank
ROA 1.62%
ROE 5.68%
ROIC 2.14%
ROA(3y)2.67%
ROA(5y)2.49%
ROE(3y)8.42%
ROE(5y)7.56%
ROIC(3y)2.45%
ROIC(5y)2.49%
SREA Yearly ROA, ROE, ROICSREA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • The Profit Margin of SREA (13.11%) is better than 76.92% of its industry peers.
  • SREA's Profit Margin has declined in the last couple of years.
  • SREA's Operating Margin of 22.48% is fine compared to the rest of the industry. SREA outperforms 65.38% of its industry peers.
  • In the last couple of years the Operating Margin of SREA has declined.
Industry RankSector Rank
OM 22.48%
PM (TTM) 13.11%
GM N/A
OM growth 3Y8.27%
OM growth 5Y-2.04%
PM growth 3Y-3.31%
PM growth 5Y-16.91%
GM growth 3YN/A
GM growth 5YN/A
SREA Yearly Profit, Operating, Gross MarginsSREA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. SREA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SREA is destroying value.
  • Compared to 1 year ago, SREA has more shares outstanding
  • The number of shares outstanding for SREA has been increased compared to 5 years ago.
  • Compared to 1 year ago, SREA has an improved debt to assets ratio.
SREA Yearly Shares OutstandingSREA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
SREA Yearly Total Debt VS Total AssetsSREA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • SREA has an Altman-Z score of 0.68. This is a bad value and indicates that SREA is not financially healthy and even has some risk of bankruptcy.
  • SREA has a Altman-Z score of 0.68. This is comparable to the rest of the industry: SREA outperforms 42.31% of its industry peers.
  • SREA has a Debt/Equity ratio of 1.05. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of SREA (1.05) is better than 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.05
Debt/FCF N/A
Altman-Z 0.68
ROIC/WACC0.48
WACC4.45%
SREA Yearly LT Debt VS Equity VS FCFSREA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B 20B 30B

2.3 Liquidity

  • A Current Ratio of 1.59 indicates that SREA should not have too much problems paying its short term obligations.
  • SREA has a Current ratio of 1.59. This is amongst the best in the industry. SREA outperforms 100.00% of its industry peers.
  • SREA has a Quick Ratio of 1.57. This is a normal value and indicates that SREA is financially healthy and should not expect problems in meeting its short term obligations.
  • SREA has a better Quick ratio (1.57) than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.59
Quick Ratio 1.57
SREA Yearly Current Assets VS Current LiabilitesSREA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. SREA Growth Analysis

3.1 Past

  • SREA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.16%.
  • SREA shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.52% yearly.
  • The Revenue has been growing slightly by 3.92% in the past year.
  • Measured over the past years, SREA shows a small growth in Revenue. The Revenue has been growing by 3.80% on average per year.
EPS 1Y (TTM)2.16%
EPS 3Y0.83%
EPS 5Y3.52%
EPS Q2Q%-14.67%
Revenue 1Y (TTM)3.92%
Revenue growth 3Y-1.73%
Revenue growth 5Y3.8%
Sales Q2Q%-0.24%

3.2 Future

  • The Earnings Per Share is expected to grow by 8.89% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 2.53% on average over the next years.
EPS Next Y9.21%
EPS Next 2Y8.54%
EPS Next 3Y8.63%
EPS Next 5Y8.89%
Revenue Next Year3.96%
Revenue Next 2Y-0.05%
Revenue Next 3Y0.87%
Revenue Next 5Y2.53%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SREA Yearly Revenue VS EstimatesSREA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B
SREA Yearly EPS VS EstimatesSREA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

7

4. SREA Valuation Analysis

4.1 Price/Earnings Ratio

  • SREA is valuated cheaply with a Price/Earnings ratio of 4.60.
  • 84.62% of the companies in the same industry are more expensive than SREA, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 27.35. SREA is valued rather cheaply when compared to this.
  • With a Price/Forward Earnings ratio of 4.21, the valuation of SREA can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, SREA is valued cheaply inside the industry as 84.62% of the companies are valued more expensively.
  • SREA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.23.
Industry RankSector Rank
PE 4.6
Fwd PE 4.21
SREA Price Earnings VS Forward Price EarningsSREA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SREA indicates a rather cheap valuation: SREA is cheaper than 84.62% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.97
SREA Per share dataSREA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30 40

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.5
PEG (5Y)1.31
EPS Next 2Y8.54%
EPS Next 3Y8.63%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. SREA Dividend Analysis

5.1 Amount

  • SREA has a Yearly Dividend Yield of 2.80%.
  • With a Dividend Yield of 2.80, SREA pays less dividend than the industry average, which is at 3.38. 84.62% of the companies listed in the same industry pay a better dividend than SREA!
  • Compared to an average S&P500 Dividend Yield of 1.82, SREA pays a better dividend.
Industry RankSector Rank
Dividend Yield 2.8%

5.2 History

  • The dividend of SREA decreases each year by -11.29%.
  • SREA has been paying a dividend for over 5 years, so it has already some track record.
  • SREA has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-11.29%
Div Incr Years0
Div Non Decr Years2
SREA Yearly Dividends per shareSREA Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 2026 0.5 1

5.3 Sustainability

  • 91.48% of the earnings are spent on dividend by SREA. This is not a sustainable payout ratio.
DP91.48%
EPS Next 2Y8.54%
EPS Next 3Y8.63%
SREA Yearly Income VS Free CF VS DividendSREA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B -4B -6B
SREA Dividend Payout.SREA Dividend Payout, showing the Payout Ratio.SREA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SREA Fundamentals: All Metrics, Ratios and Statistics

SEMPRA - SRE 5 3/4 07/01/2079

NYSE:SREA (4/27/2026, 8:18:41 PM)

21.7

+0.01 (+0.05%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)02-26
Earnings (Next)05-07
Inst Owners94.04%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap14.18B
Revenue(TTM)13.70B
Net Income(TTM)1.80B
Analysts80
Price Target23.53 (8.43%)
Short Float %0%
Short Ratio0.41
Dividend
Industry RankSector Rank
Dividend Yield 2.8%
Yearly Dividend2.52
Dividend Growth(5Y)-11.29%
DP91.48%
Div Incr Years0
Div Non Decr Years2
Ex-Date03-13
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.36%
Min EPS beat(2)8.22%
Max EPS beat(2)20.49%
EPS beat(4)4
Avg EPS beat(4)10.23%
Min EPS beat(4)4.16%
Max EPS beat(4)20.49%
EPS beat(8)4
Avg EPS beat(8)1.35%
EPS beat(12)8
Avg EPS beat(12)2.29%
EPS beat(16)12
Avg EPS beat(16)4.13%
Revenue beat(2)1
Avg Revenue beat(2)-0.62%
Min Revenue beat(2)-8.34%
Max Revenue beat(2)7.1%
Revenue beat(4)1
Avg Revenue beat(4)-2.3%
Min Revenue beat(4)-8.34%
Max Revenue beat(4)7.1%
Revenue beat(8)1
Avg Revenue beat(8)-11.75%
Revenue beat(12)2
Avg Revenue beat(12)-5.28%
Revenue beat(16)5
Avg Revenue beat(16)-2.27%
PT rev (1m)-4.99%
PT rev (3m)-9.95%
EPS NQ rev (1m)0.93%
EPS NQ rev (3m)4.05%
EPS NY rev (1m)0.11%
EPS NY rev (3m)0.04%
Revenue NQ rev (1m)0.36%
Revenue NQ rev (3m)-0.72%
Revenue NY rev (1m)1.18%
Revenue NY rev (3m)-1.82%
Valuation
Industry RankSector Rank
PE 4.6
Fwd PE 4.21
P/S 1.03
P/FCF N/A
P/OCF 3.11
P/B 0.45
P/tB 0.45
EV/EBITDA 7.97
EPS(TTM)4.72
EY21.75%
EPS(NY)5.15
Fwd EY23.75%
FCF(TTM)-10.83
FCFYN/A
OCF(TTM)6.99
OCFY32.2%
SpS20.97
BVpS48.39
TBVpS48.39
PEG (NY)0.5
PEG (5Y)1.31
Graham Number71.6862 (230.35%)
Profitability
Industry RankSector Rank
ROA 1.62%
ROE 5.68%
ROCE 3.46%
ROIC 2.14%
ROICexc 2.14%
ROICexgc 2.14%
OM 22.48%
PM (TTM) 13.11%
GM N/A
FCFM N/A
ROA(3y)2.67%
ROA(5y)2.49%
ROE(3y)8.42%
ROE(5y)7.56%
ROIC(3y)2.45%
ROIC(5y)2.49%
ROICexc(3y)2.46%
ROICexc(5y)2.51%
ROICexgc(3y)2.51%
ROICexgc(5y)2.57%
ROCE(3y)3.9%
ROCE(5y)4%
ROICexgc growth 3Y-3.39%
ROICexgc growth 5Y-7.53%
ROICexc growth 3Y-2.5%
ROICexc growth 5Y-6.96%
OM growth 3Y8.27%
OM growth 5Y-2.04%
PM growth 3Y-3.31%
PM growth 5Y-16.91%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 1.05
Debt/FCF N/A
Debt/EBITDA 5.87
Cap/Depr 454.27%
Cap/Sales 84.97%
Interest Coverage 2.13
Cash Conversion 80.9%
Profit Quality N/A
Current Ratio 1.59
Quick Ratio 1.57
Altman-Z 0.68
F-Score6
WACC4.45%
ROIC/WACC0.48
Cap/Depr(3y)410.76%
Cap/Depr(5y)370.89%
Cap/Sales(3y)69.3%
Cap/Sales(5y)59.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.16%
EPS 3Y0.83%
EPS 5Y3.52%
EPS Q2Q%-14.67%
EPS Next Y9.21%
EPS Next 2Y8.54%
EPS Next 3Y8.63%
EPS Next 5Y8.89%
Revenue 1Y (TTM)3.92%
Revenue growth 3Y-1.73%
Revenue growth 5Y3.8%
Sales Q2Q%-0.24%
Revenue Next Year3.96%
Revenue Next 2Y-0.05%
Revenue Next 3Y0.87%
Revenue Next 5Y2.53%
EBIT growth 1Y3.98%
EBIT growth 3Y6.4%
EBIT growth 5Y1.69%
EBIT Next Year92.6%
EBIT Next 3Y26.03%
EBIT Next 5Y21.85%
FCF growth 1Y-68.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-6.97%
OCF growth 3Y58.71%
OCF growth 5Y11.99%

SEMPRA - SRE 5 3/4 07/01/2079 / SREA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for SEMPRA - SRE 5 3/4 07/01/2079?

ChartMill assigns a fundamental rating of 4 / 10 to SREA.


Can you provide the valuation status for SEMPRA - SRE 5 3/4 07/01/2079?

ChartMill assigns a valuation rating of 7 / 10 to SEMPRA - SRE 5 3/4 07/01/2079 (SREA). This can be considered as Undervalued.


Can you provide the profitability details for SEMPRA - SRE 5 3/4 07/01/2079?

SEMPRA - SRE 5 3/4 07/01/2079 (SREA) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for SREA stock?

The Price/Earnings (PE) ratio for SEMPRA - SRE 5 3/4 07/01/2079 (SREA) is 4.6 and the Price/Book (PB) ratio is 0.45.


Can you provide the financial health for SREA stock?

The financial health rating of SEMPRA - SRE 5 3/4 07/01/2079 (SREA) is 4 / 10.